Symptoms of Low Vitamin B9 (Folate): Causes and Treatment
Deficiency
Symptoms & causes
Folate (vitamin B9) deficiency is a genuine and common nutritional deficiency with serious consequences — megaloblastic anemia in adults and neural tube defects in embryos; it is one of the most important preventable nutritional problems in pregnancy, and the folic acid fortification of grain foods has dramatically reduced neural tube defect rates in the US.
Folate deficiency is a clinically significant nutritional problem that causes megaloblastic anemia in adults and devastating neural tube defects in developing embryos. The hallmark symptoms — fatigue, pallor, and shortness of breath — are indistinguishable from B12 deficiency on a standard blood count, which makes diagnostic caution essential. Because the neural tube closes within the first month of pregnancy, often before a woman knows she is pregnant, adequate folate intake must begin before conception, making this a critical public health priority for all women of childbearing age.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Symptoms of low Folate (vitamin B9) — a water-soluble B vitamin that serves as a coenzyme in its active tetrahydrofolate form for one-carbon transfer reactions central to DNA synthesis, DNA repair, and amino acid metabolism, particularly the remethylation of homocysteine to methionine via methylenetetrahydrofolate reductase. Dietary folate is the polyglutamate form found naturally in foods, while folic acid is the synthetic monoglutamate form used in fortified foods and supplements. Folic acid has higher bioavailability, and intake is expressed as dietary folate equivalents: 1 mcg of food folate equals 1 mcg DFE, while 1 mcg of folic acid taken with food equals 1.7 mcg DFE, and 1 mcg of folic acid on an empty stomach equals 2 mcg DFE. The RDA for adults is 400 mcg DFE per day, increasing to 600 mcg DFE during pregnancy and 500 mcg DFE during lactation. The tolerable upper intake level for synthetic folic acid is 1,000 mcg per day due to the risk of masking B12 deficiency at higher doses. Rich food sources include dark leafy greens, liver, legumes, asparagus, avocado, broccoli, and fortified cereals.
Everyday signs are on the left; the ones on the right mean it's time to check in with a clinician.
Everyday signs
Common symptoms
- Megaloblastic anemia — the hallmark: large, oval red blood cells with hypersegmented neutrophils on peripheral blood smear
- Fatigue, weakness, pallor, shortness of breath, and palpitations
- Glossitis — a smooth, painful tongue
- Mouth sores and poor appetite
- Weight loss
- Elevated serum homocysteine, a risk marker for cardiovascular disease and thrombosis
- In pregnancy: neural tube defects including spina bifida and anencephaly
Don't wait
See a doctor if
- Any woman planning pregnancy or capable of becoming pregnant should discuss folic acid supplementation with a clinician — neural tube defect prevention requires adequate folate before conception, as the neural tube closes by day 28 of gestation
- Megaloblastic anemia symptoms require clinical evaluation — B12 and folate levels must be measured together because treatment differs, and substituting folic acid for B12 can mask B12 deficiency while neurological damage progresses
- Elevated homocysteine on cardiovascular screening warrants folate and B12 assessment
Who is most likely to run low
Some people are more prone to falling short than others — including many people on a weight-loss journey who are simply eating less.
- Women of childbearing age, especially those not taking folic acid supplements
- People with celiac disease or Crohn's disease
- Chronic alcohol users
- People on methotrexate, sulfasalazine, or anticonvulsant medications
- Older adults with poor dietary intake
- People with MTHFR C677T homozygosity
- Pregnant women with inadequate supplementation
- Infants of folate-deficient mothers
What causes low Folate (vitamin B9) — a water-soluble B vitamin that serves as a coenzyme in its active tetrahydrofolate form for one-carbon transfer reactions central to DNA synthesis, DNA repair, and amino acid metabolism, particularly the remethylation of homocysteine to methionine via methylenetetrahydrofolate reductase. Dietary folate is the polyglutamate form found naturally in foods, while folic acid is the synthetic monoglutamate form used in fortified foods and supplements. Folic acid has higher bioavailability, and intake is expressed as dietary folate equivalents: 1 mcg of food folate equals 1 mcg DFE, while 1 mcg of folic acid taken with food equals 1.7 mcg DFE, and 1 mcg of folic acid on an empty stomach equals 2 mcg DFE. The RDA for adults is 400 mcg DFE per day, increasing to 600 mcg DFE during pregnancy and 500 mcg DFE during lactation. The tolerable upper intake level for synthetic folic acid is 1,000 mcg per day due to the risk of masking B12 deficiency at higher doses. Rich food sources include dark leafy greens, liver, legumes, asparagus, avocado, broccoli, and fortified cereals.
- Inadequate dietary intake — the most common cause; foods high in folate are under-consumed in many Western diets
- Malabsorption — celiac disease, Crohn's disease, and short bowel syndrome impair folate absorption in the proximal small intestine
- Medications — methotrexate directly inhibits dihydrofolate reductase; trimethoprim also inhibits DHFR; sulfasalazine impairs folate absorption; anticonvulsants including phenytoin, carbamazepine, and valproate reduce folate status
- Alcoholism — impairs folate absorption, increases urinary folate excretion, and reduces dietary intake
- Increased demand — pregnancy requires enormous folate for fetal cell division and DNA synthesis; hemolytic anemia causes rapid red cell turnover
- MTHFR C677T homozygosity — reduces conversion of 5,10-methyleneTHF to 5-methylTHF, increasing folate requirements
How low levels are diagnosed
Serum folate reflects recent intake over approximately two weeks and may normalize rapidly after a single dietary change. RBC folate is a more stable indicator of long-term folate status and reflects tissue stores. Elevated serum homocysteine is non-specific and also elevated in B12 and B6 deficiency. A complete blood count shows macrocytosis with elevated mean corpuscular volume and hypersegmented neutrophils — findings identical to B12 deficiency, requiring simultaneous measurement of B12 and folate levels to distinguish between the two.
How it's corrected
Most gaps close with food first, and supplementation when a clinician recommends it.
Food-first approach: dark leafy greens, liver, legumes, avocado, broccoli, and fortified cereals. Supplementation: folic acid 400 mcg daily for the general adult population; 400 to 800 mcg daily for women of childbearing age as a standard prenatal vitamin. Women with a prior neural tube defect pregnancy or on valproate require 4,000 to 5,000 mcg daily prescribed by a clinician. For megaloblastic anemia, treatment is typically 1 mg daily of oral folic acid for three to four months, but B12 status must be confirmed first. Methylfolate supplements are marketed to people with MTHFR polymorphisms and may bypass the impaired metabolic step in C677T homozygotes, but clinical superiority over standard folic acid has not been definitively established by large randomized controlled trials.
How to keep levels up
A varied diet with dark green vegetables, legumes, and fortified grains; folic acid 400 mcg daily supplement for all women capable of pregnancy; folic acid 4 mg daily for high-risk pregnancies including prior neural tube defect or anticonvulsant use; compliance with US grain fortification, which has mandated folic acid in enriched flour, pasta, bread, and cereals since 1998.
When to see a clinician
All women planning pregnancy should initiate 400 to 800 mcg of folic acid daily at least one month before attempting conception, ideally three months before. Any woman with a prior neural tube defect pregnancy should see a clinician before the next pregnancy for high-dose folic acid prescription. Megaloblastic anemia requires clinical evaluation to distinguish B12 from folate deficiency before any treatment begins. Methotrexate users should discuss folate supplementation protocols with their prescribing physician, as recommendations are specific to the indication and dose. Routine MTHFR genetic testing is not recommended by the American College of Medical Genetics and Genomics for the general population, as most people with MTHFR variants respond adequately to standard folic acid doses.
Neural Tube Defects: Why Folate Is the Most Consequential Prenatal Nutrient — And Why You Must Start Before You Know You Are Pregnant
Folate's single most important clinical role is preventing neural tube defects, catastrophic birth defects that occur before most women even realize they are pregnant. The neural tube — the embryonic structure that becomes the brain and spinal cord — forms and closes between gestational days 21 and 28, a window that typically ends before a missed period prompts a pregnancy test.
This embryological timeline creates a stark clinical reality: adequate folate must already be circulating in a woman's body at the moment of conception. Waiting until a positive pregnancy test to start folic acid is too late for neural tube closure. This is why the CDC and the U.S. Preventive Services Task Force recommend that all women capable of becoming pregnant take 400 to 800 mcg of folic acid daily, regardless of pregnancy plans.
The two primary neural tube defects are spina bifida and anencephaly. In spina bifida, the vertebral arch fails to close completely, leaving the spinal cord exposed or unprotected. Children born with spina bifida survive but face varying degrees of lifelong disability, including motor deficits, hydrocephalus, and bladder and bowel dysfunction. Anencephaly, the failure of the upper neural tube to close, results in absent brain development and is typically fatal shortly after birth.
The United States' mandatory folic acid fortification of enriched grain products, implemented in 1998, stands as one of the most successful public health interventions in modern history. By adding folic acid to flour, bread, pasta, and cereals, neural tube defect rates dropped by approximately 28%. Yet disparities persist: rates remained higher in Hispanic women, partly because corn masa flour — a dietary staple in many Hispanic communities — was not included in the original fortification mandate until the FDA extended the rule in 2016.
Bottom line
Folate's single most important clinical role is NTD prevention — and because the neural tube closes before most women know they're pregnant, all women of childbearing age should be taking folic acid daily, not starting it after a positive test.
Megaloblastic Anemia: How to Distinguish Folate from B12 Deficiency — And Why Getting It Wrong Is Dangerous
Megaloblastic anemia is the classic adult presentation of folate deficiency, but it carries a diagnostic trap that every clinician and patient should understand: it looks identical to B12 deficiency on a standard blood count. Both deficiencies impair DNA synthesis, causing red blood cell precursors to grow large without dividing properly. The result is macrocytosis — an elevated mean corpuscular volume — and hypersegmented neutrophils visible on a peripheral blood smear.
The danger lies in what happens when the wrong treatment is given. If a patient with undiagnosed B12 deficiency receives high-dose folic acid, the megaloblastic anemia can resolve completely. The blood count normalizes, and the patient may feel better — while B12-mediated neurological damage continues to progress silently. B12 deficiency causes subacute combined degeneration of the spinal cord, a demyelinating condition that produces peripheral neuropathy, gait disturbances, and eventually irreversible paralysis if untreated.
This masking phenomenon is why clinical guidelines are unambiguous: serum B12 and folate levels must always be measured together when megaloblastic anemia is found. If B12 is borderline, additional tests like methylmalonic acid and homocysteine can clarify the picture. Isolated folate deficiency does not cause neurological damage, but treating B12 deficiency with folate alone allows the neurological presentation to become the first recognized sign — by which time damage may be advanced and permanent.
The diagnostic protocol is straightforward: never start high-dose folic acid without knowing B12 status. For patients with clear folate deficiency and normal B12, treatment is safe and effective. For those with low or borderline B12, B12 replacement must accompany or precede folate therapy. This single precaution prevents one of the most avoidable neurological catastrophes in clinical medicine.
Bottom line
Megaloblastic anemia from folate deficiency looks identical to B12 deficiency on blood count — always test both before treating; giving folic acid for undiagnosed B12 deficiency masks anemia while allowing irreversible neurological damage to progress.
MTHFR Polymorphisms: Separating Real Risk from the Wellness Industry's Over-Testing Narrative
The MTHFR C677T polymorphism has become one of the most over-tested and over-interpreted genetic variants in consumer health, fueling a lucrative market for expensive methylfolate supplements and direct-to-consumer genetic testing. The biochemistry is real: the MTHFR enzyme converts 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the active circulating form of folate. The C677T variant reduces enzyme activity, with homozygotes showing approximately 70% reduction in activity and mildly elevated homocysteine levels.
What the wellness industry often omits is that this is a common polymorphism, not a rare disorder. Approximately 40% of the US population carries one copy of the C677T variant, and 10 to 15% carry two copies. These are normal human genetic variations, not disease-causing mutations. The American College of Medical Genetics and Genomics explicitly recommends against routine MTHFR testing in the general population because the result does not change clinical management.
The evidence gap for methylfolate is substantial. While methylfolate bypasses the enzymatic step impaired by MTHFR variants, no large randomized controlled trial has demonstrated that methylfolate supplementation produces superior clinical outcomes — better pregnancy results, lower homocysteine, or reduced cardiovascular events — compared to standard folic acid in MTHFR carriers. Standard folic acid at adequate doses normalizes folate status in virtually all individuals with MTHFR polymorphisms.
The direct-to-consumer testing industry has capitalized on MTHFR anxiety, often recommending expensive methylfolate supplements that cost many times more than standard folic acid. Major medical societies, including the ACMG and the American Heart Association, maintain that elevated homocysteine is a better clinical indicator than genotype alone, and that routine MTHFR testing does not improve patient outcomes.
Bottom line
MTHFR C677T homozygosity is common and does not require expensive methylfolate supplements in most cases — standard folic acid is adequate; routine MTHFR testing is not recommended by major medical societies.
Methotrexate, Anticonvulsants, and Drug-Induced Folate Deficiency: The Medication Interactions That Matter
Several commonly prescribed medications cause clinically significant folate deficiency through distinct mechanisms, and understanding these interactions is essential for patients and clinicians alike. Methotrexate is the most direct offender: it potently inhibits dihydrofolate reductase, the enzyme that activates dietary folate to its usable tetrahydrofolate form. Used in rheumatoid arthritis, psoriasis, and certain cancers, methotrexate creates a predictable folate deficit at any dose.
For rheumatoid arthritis and psoriasis patients on low-dose weekly methotrexate, folate supplementation is standard care. The American College of Rheumatology recommends 1 to 5 mg of folic acid on non-methotrexate days, which reduces gastrointestinal, mucosal, and hepatic side effects without diminishing the drug's anti-inflammatory efficacy. Importantly, folate does not interfere with methotrexate's cancer-killing mechanism, as cancer cells have distinct folate metabolism pathways.
Anticonvulsant medications — including phenytoin, carbamazepine, and valproate — reduce folate status through multiple mechanisms: impaired intestinal absorption, increased hepatic catabolism, and reduced dietary intake. Women taking these medications during pregnancy face compounded risk and require high-dose folic acid of 4 to 5 mg daily, far above the standard prenatal dose. Sulfasalazine, used for inflammatory bowel disease and rheumatoid arthritis, directly inhibits folate absorption in the small intestine, and supplementation is typically recommended for patients on long-term therapy.
Trimethoprim, a common antibiotic, also inhibits dihydrofolate reductase like methotrexate. Short-term courses are generally not clinically significant for folate status, but prolonged use can reduce folate levels. For any patient on these medications, folate status should be monitored, and supplementation discussed with the prescribing physician.
Bottom line
Methotrexate causes clinically significant folate deficiency at any dose; supplementing folic acid on non-methotrexate days reduces side effects without compromising efficacy — this is guideline-standard care.
Folate, Homocysteine, and GLP-1 Therapy: Cardiovascular Risk, Reduced Dietary Intake, and the Fortification Safety Net
GLP-1 receptor agonists like semaglutide and tirzepatide reduce caloric intake substantially, which can lower consumption of folate-rich foods including dark leafy greens, legumes, and whole grains. The US folic acid fortification program provides a partial safety net — enriched bread, pasta, and cereals supply folic acid even when overall food intake drops — but patients following extremely restricted or unfortified diets may face increased deficiency risk.
Elevated homocysteine is a cardiovascular risk marker particularly relevant to the GLP-1 therapy population, which often has elevated baseline cardiovascular risk. Folate, vitamin B6, and vitamin B12 all participate in homocysteine metabolism, and adequate intake of all three reduces homocysteine levels. However, an important nuance is that large randomized controlled trials, including VITATOPS and HOPE-2, demonstrated that lowering homocysteine with B vitamins did not consistently reduce cardiovascular events, despite successfully reducing homocysteine levels.
For women on GLP-1 therapy who might become pregnant, folate status demands particular attention. Weight loss can restore fertility in women with obesity-related anovulation, sometimes unexpectedly. The neural tube closes before most women recognize pregnancy, making preconception folate status the clinical priority. A standard prenatal vitamin or multivitamin providing 400 to 800 mcg of folic acid daily should be a routine part of care for women of childbearing age on GLP-1 therapy.
There is no known pharmacokinetic interaction between folate and semaglutide or tirzepatide. Metformin, which is sometimes co-prescribed with GLP-1 agonists, is more strongly associated with B12 malabsorption than with folate depletion. The primary folate concern on GLP-1 therapy is dietary — reduced intake of folate-rich foods — and this is easily addressed with standard supplementation.
Bottom line
Women on GLP-1 therapy who could become pregnant should ensure 400 to 800 mcg of folic acid daily regardless of weight loss goals — the neural tube closes before most women recognize pregnancy, making preconception folate status the clinical priority.
What most pages leave out
The MTHFR wellness industry narrative overstates the clinical significance of common MTHFR polymorphisms, promotes expensive methylfolate supplements over inexpensive standard folic acid without RCT evidence of superiority, and has driven enormous unnecessary direct-to-consumer genetic testing. The homocysteine-cardiovascular-risk story is more complex than typically presented — lowering homocysteine with B vitamins has not been shown to reduce cardiovascular events in large RCTs despite reducing homocysteine levels. The key competitor gap is also the B12-masking danger — almost no general wellness content adequately conveys this risk.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
The hallmark symptom is megaloblastic anemia, which causes fatigue, pallor, shortness of breath, and palpitations due to abnormally large, immature red blood cells. Other symptoms include a smooth, painful tongue (glossitis), mouth sores, poor appetite, and weight loss. In embryos, folate deficiency prevents proper neural tube closure, leading to birth defects such as spina bifida and anencephaly.
The Recommended Dietary Allowance during pregnancy is 600 mcg DFE per day. Standard clinical guidance recommends that all women capable of becoming pregnant take 400 to 800 mcg of folic acid daily starting at least one month before conception. Women with a prior neural tube defect pregnancy should take a prescribed high dose of 4 mg daily under clinician supervision.
Folate is the naturally occurring polyglutamate form found in foods like leafy greens and legumes. Folic acid is the synthetic monoglutamate form used in supplements and fortified foods. Folic acid has higher bioavailability than natural folate, and both are measured using Dietary Folate Equivalents (DFE) to account for these absorption differences.
Unlike vitamin B12 deficiency, isolated folate deficiency does not cause the demyelination or spinal cord degeneration seen with B12 deficiency. The primary neurological danger of folate is indirect: giving high-dose folic acid to someone with undiagnosed B12 deficiency can correct the anemia while allowing irreversible neurological damage from the B12 deficiency to progress silently.
For most people with the common MTHFR C677T polymorphism, standard folic acid at adequate doses is sufficient. Major medical societies, including the American College of Medical Genetics and Genomics, do not recommend routine MTHFR testing or methylfolate supplementation over standard folic acid, as large RCTs have not established clinical superiority of methylfolate.
Beef liver is the most concentrated source, providing about 215 mcg per 3-ounce serving. Other excellent sources include dark leafy greens like spinach, black-eyed peas and other legumes, asparagus, avocado, broccoli, and fortified breakfast cereals, which can provide up to 400 mcg per serving.
Yes. Methotrexate directly inhibits dihydrofolate reductase, the enzyme that activates folate in the body. Supplementing with 1 to 5 mg of folic acid on non-methotrexate days is standard practice to reduce gastrointestinal and mucosal side effects without compromising the drug's effectiveness for rheumatoid arthritis or psoriasis.
A standard multivitamin or prenatal vitamin covering 400 mcg DFE per day is a reasonable precaution for GLP-1 patients whose food variety may be reduced. Women of childbearing age on GLP-1 therapy should ensure adequate folic acid intake for potential pregnancy regardless of weight loss status, as the neural tube closes before most women recognize they are pregnant.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
Symptoms of Low Vitamin C: Causes and Treatment
Vitamin C deficiency (scurvy) still occurs today, causing bleeding gums, fatigue, and poor wound healing. Learn the symptoms, causes, and evidence-based treatment.
Read moreSymptoms of Low Vitamin K2: Causes and Treatment
Vitamin K2 deficiency symptoms include easy bruising and bleeding. Learn who's at risk, how it differs from K1, and the critical warfarin interaction.
Read moreSymptoms of Low Vitamin B: Causes and Treatment
Vitamin B deficiency isn't one condition—it's eight. Learn the distinct symptoms of B12, folate, B1, and B3 deficiency, who's at risk, and when to see a doctor.
Read moreSymptoms of Low Vitamin B2 (Riboflavin): Causes, Treatment, and Who Is at Risk
Riboflavin (B2) deficiency causes mouth sores, magenta tongue, and eye irritation. Learn who is at risk, how it's diagnosed, and how to treat it safely.
Read moreSymptoms of Low Vitamin B1 (Thiamine): Causes & Treatment
Thiamine deficiency can cause Wernicke encephalopathy, a medical emergency. Learn the symptoms of low vitamin B1, causes like alcohol use, and why IV treatment is critical.
Read moreSymptoms of Low Vitamin B3 (Niacin): Causes & Treatment
Niacin deficiency causes pellagra—the 'four Ds': dermatitis, diarrhea, dementia, and death. Learn the symptoms, causes, and how treatment differs from high-dose niacin.
Read moreOn a GLP-1, or thinking about one?
Nutrient gaps are more common on a GLP-1 because you eat less — care that includes real clinical oversight helps you do it safely.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.